Motherson Sumi Wiring India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 11:39 am

Competitors of Motherson Sumi Wiring India Ltd

All Competitor Stocks of Motherson Sumi Wiring India Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:05 pm

Below is a detailed analysis of the quarterly data for Motherson Sumi Wiring India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,494.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,510.00 Cr. (Mar 2025) to 2,494.00 Cr., marking a decrease of 16.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,250.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,238.00 Cr. (Mar 2025) to 2,250.00 Cr., marking an increase of 12.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 244.00 Cr.. The value appears to be declining and may need further review. It has decreased from 271.00 Cr. (Mar 2025) to 244.00 Cr., marking a decrease of 27.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Mar 2025) to 10.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 49.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 48.00 Cr. (Mar 2025) to 49.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 190.00 Cr.. The value appears to be declining and may need further review. It has decreased from 220.00 Cr. (Mar 2025) to 190.00 Cr., marking a decrease of 30.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 165.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 22.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.22. The value appears to be declining and may need further review. It has decreased from 0.25 (Mar 2025) to 0.22, marking a decrease of 0.03.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:03 am

Growth

Last Updated: September 5, 2025, 3:51 pm

Balance Sheet

Last Updated: November 9, 2025, 4:12 pm

Below is a detailed analysis of the balance sheet data for Motherson Sumi Wiring India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 663.00 Cr.. The value appears strong and on an upward trend. It has increased from 442.00 Cr. (Mar 2025) to 663.00 Cr., marking an increase of 221.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,179.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,256.00 Cr. (Mar 2025) to 1,179.00 Cr., marking a decrease of 77.00 Cr..
• For Borrowings, as of Sep 2025, the value is 253.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 269.00 Cr. (Mar 2025) to 253.00 Cr., marking a decrease of 16.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,897.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,761.00 Cr. (Mar 2025) to 1,897.00 Cr., marking an increase of 136.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,992.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,729.00 Cr. (Mar 2025) to 3,992.00 Cr., marking an increase of 263.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 716.00 Cr.. The value appears strong and on an upward trend. It has increased from 691.00 Cr. (Mar 2025) to 716.00 Cr., marking an increase of 25.00 Cr..
• For CWIP, as of Sep 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 53.00 Cr., marking an increase of 16.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 3,222.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,002.00 Cr. (Mar 2025) to 3,222.00 Cr., marking an increase of 220.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,992.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,729.00 Cr. (Mar 2025) to 3,992.00 Cr., marking an increase of 263.00 Cr..

Notably, the Reserves (1,179.00 Cr.) exceed the Borrowings (253.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Motherson Sumi Wiring India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 24) to 1.37, marking a decrease of 0.07.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 24) to 1.37, marking a decrease of 0.07.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.78. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 1.78.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.84. It has increased from 3.79 (Mar 24) to 3.84, marking an increase of 0.05.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.84. It has increased from 3.79 (Mar 24) to 3.84, marking an increase of 0.05.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.80 (Mar 24) to 0.85, marking an increase of 0.05.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 21.08. It has increased from 18.84 (Mar 24) to 21.08, marking an increase of 2.24.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 2.28. This value is within the healthy range. It has decreased from 2.31 (Mar 24) to 2.28, marking a decrease of 0.03.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.88. This value is within the healthy range. It has decreased from 1.97 (Mar 24) to 1.88, marking a decrease of 0.09.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 1.91 (Mar 24) to 1.82, marking a decrease of 0.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 2. It has decreased from 1.44 (Mar 24) to 1.37, marking a decrease of 0.07.
• For PBDIT Margin (%), as of Mar 25, the value is 10.82. This value is within the healthy range. It has decreased from 12.24 (Mar 24) to 10.82, marking a decrease of 1.42.
• For PBIT Margin (%), as of Mar 25, the value is 8.90. This value is below the healthy minimum of 10. It has decreased from 10.48 (Mar 24) to 8.90, marking a decrease of 1.58.
• For PBT Margin (%), as of Mar 25, the value is 8.64. This value is below the healthy minimum of 10. It has decreased from 10.15 (Mar 24) to 8.64, marking a decrease of 1.51.
• For Net Profit Margin (%), as of Mar 25, the value is 6.50. This value is within the healthy range. It has decreased from 7.66 (Mar 24) to 6.50, marking a decrease of 1.16.
• For Return on Networth / Equity (%), as of Mar 25, the value is 35.67. This value is within the healthy range. It has decreased from 38.06 (Mar 24) to 35.67, marking a decrease of 2.39.
• For Return on Capital Employeed (%), as of Mar 25, the value is 43.19. This value is within the healthy range. It has decreased from 45.66 (Mar 24) to 43.19, marking a decrease of 2.47.
• For Return On Assets (%), as of Mar 25, the value is 16.24. This value is within the healthy range. It has decreased from 20.33 (Mar 24) to 16.24, marking a decrease of 4.09.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.71. It has decreased from 2.76 (Mar 24) to 2.71, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.94 (Mar 24) to 1.58, marking a decrease of 0.36.
• For Quick Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.01 (Mar 24) to 0.86, marking a decrease of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 7.69, marking an increase of 3.04.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 94.85. This value exceeds the healthy maximum of 50. It has increased from 45.02 (Mar 24) to 94.85, marking an increase of 49.83.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 73.22. This value exceeds the healthy maximum of 50. It has increased from 36.58 (Mar 24) to 73.22, marking an increase of 36.64.
• For Earning Retention Ratio (%), as of Mar 25, the value is 5.15. This value is below the healthy minimum of 40. It has decreased from 54.98 (Mar 24) to 5.15, marking a decrease of 49.83.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 26.78. This value is below the healthy minimum of 40. It has decreased from 63.42 (Mar 24) to 26.78, marking a decrease of 36.64.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 40.85. This value is within the healthy range. It has increased from 37.37 (Mar 24) to 40.85, marking an increase of 3.48.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 25.53. This value is within the healthy range. It has increased from 24.38 (Mar 24) to 25.53, marking an increase of 1.15.
• For Enterprise Value (Cr.), as of Mar 25, the value is 22,787.73. It has decreased from 28,905.64 (Mar 24) to 22,787.73, marking a decrease of 6,117.91.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.45. This value is within the healthy range. It has decreased from 3.47 (Mar 24) to 2.45, marking a decrease of 1.02.
• For EV / EBITDA (X), as of Mar 25, the value is 22.58. This value exceeds the healthy maximum of 15. It has decreased from 28.34 (Mar 24) to 22.58, marking a decrease of 5.76.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 2.47, marking a decrease of 1.03.
• For Retention Ratios (%), as of Mar 25, the value is 5.14. This value is below the healthy minimum of 30. It has decreased from 54.97 (Mar 24) to 5.14, marking a decrease of 49.83.
• For Price / BV (X), as of Mar 25, the value is 13.55. This value exceeds the healthy maximum of 3. It has decreased from 17.39 (Mar 24) to 13.55, marking a decrease of 3.84.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 2.47, marking a decrease of 1.03.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness